KRDI in Transplant-Eligible MM
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
KRDI in Transplant-Eligible MM is a clinical trial[1].
Key Facts
- KRDI in Transplant-Eligible MM is in the country of United States[2].
- KRDI in Transplant-Eligible MM's instance of is recorded as clinical trial[3].
- KRDI in Transplant-Eligible MM's start time is recorded as +2020-07-31T00:00:00Z[4].
- KRDI in Transplant-Eligible MM's end time is recorded as +2021-09-30T00:00:00Z[5].
- KRDI in Transplant-Eligible MM's contributor to the creative work or subject is recorded as Sanofi[6].
- KRDI in Transplant-Eligible MM's sponsor is recorded as Massachusetts General Hospital[7].
- KRDI in Transplant-Eligible MM's main subject is recorded as multiple myeloma[8].
- KRDI in Transplant-Eligible MM's number of participants is recorded as {'unit': '1', 'amount': '+50'}[9].
- KRDI in Transplant-Eligible MM's title is recorded as A Phase II Study of Once Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Isatuximab in Newly Diagnosed, Transplant-Eligible Multiple Myeloma[10].
- KRDI in Transplant-Eligible MM's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- KRDI in Transplant-Eligible MM's ClinicalTrials.gov ID is recorded as NCT04430894[12].
- KRDI in Transplant-Eligible MM's research intervention is recorded as (RS)-cyclophosphamide[13].
- KRDI in Transplant-Eligible MM's research intervention is recorded as (RS)-lenalidomide[14].
- KRDI in Transplant-Eligible MM's clinical trial phase is recorded as phase II clinical trial[15].
- KRDI in Transplant-Eligible MM's research site is recorded as Massachusetts General Hospital[16].
- KRDI in Transplant-Eligible MM's research site is recorded as Beth Israel Deaconess Medical Center[17].
- KRDI in Transplant-Eligible MM's research site is recorded as Dana–Farber Cancer Institute[18].
- KRDI in Transplant-Eligible MM's research subject recruitment status is recorded as not yet recruiting[19].
- KRDI in Transplant-Eligible MM's study type is recorded as interventional study[20].